PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Tavipec (Spicae aetheroleum), a phytomedicine from L. latifolia, significantly lowered the Major Symptom Score (MSS) compared to placebo by day 8 [PMID: 31210177].
Spicae aetheroleum showed a significant mean decrease in the bronchitis severity score (BSS) at day 7 and day 10 compared to placebo [PMID: 29209859].
Oral doses of Tavipec may provide mild to moderate symptom relief in patients with viral respiratory diseases [PMID: 32837899].
L. latifolia essential oil demonstrated antibacterial activity against Staphylococcus aureus, Listeria monocytogenes [PMID: 33128531], and Bacillus cereus [PMID: 41202180].
Safety & adverse effects
Pregnancy & lactation
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 33164294 (2021) — Is it safe to consume traditional medicinal plants during pregnancy? · Phytotherapy research : PTR
- 2.PMID: 29257083 (2017) — Dynamics of Monoterpene Formation in Spike Lavender Plants. · Metabolites
- 3.PMID: 25761625 (2015) — Essential oils and distilled straws of lavender and lavandin: a review of current use and potential application in white biotechnology. · Applied microbiology and biotechnology
- 4.PMID: 33128531 (2021) — Synergistic antibacterial combination of Lavandula latifolia Medik. essential oil with camphor. · Zeitschrift fur Naturforschung. C, Journal of biosciences
- 5.PMID: 26441063 (2016) — Lavandula angustifolia and Lavandula latifolia Essential Oils from Spain: Aromatic Profile and Bioactivities.